Kinetics and specificity of T and B cell responses in relapsing experimental allergic encephalomyelitis.
Open Access
- 1 March 1987
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 138 (5) , 1434-1441
- https://doi.org/10.4049/jimmunol.138.5.1434
Abstract
T and B cell responses to myelin basic protein (MBP) and its relevant peptide fragments were examined throughout the course of MBP-induced relapsing experimental allergic encephalomyelitis (REAE) in (SJL X PL)F1 mice. T cell reactivity, measured by the antigen-driven proliferation of lymph node T cells in vitro, was directed predominantly against the encephalitogenic MBP-P2 peptide (amino acids 1 to 37) at all stages of disease. Levels of responsiveness did not correlate with disease expression, but declined over time to a relapse level that was four- to sixfold lower than that observed during peak acute stage reactivity. Relapse responses were further distinguished by the detection of host I-E restrictions on Lyt-1+ T cell recognition of P2, P2 recognition by acute-stage T cells occurring solely in the context of host I-A molecules. These data imply an increase in the heterogeneity of relapse T cell responses to MBP to include clones restricted by additional class II glycoproteins. A role for additional CNS autoantigens in the stimulation of relapse T cells is also considered. Serum antibody responses to MBP or the P2 fragment fluctuated randomly throughout R-EAE when total antibody activity (IgM plus IgG) was measured. However, analysis of individual isotypes of IgG immunoglobulins revealed an apparent correlation between peak antigen-binding activity and disease expression which may reflect either an effector or regulatory role for humoral immunity in recurrent EAE. Patterns of early antibody reactivity also distinguished F1 mice that developed or failed to develop disease signs after immunization, the latter exhibiting a consistent drop in antigen-binding activity 4 to 5 days before the usual onset of acute-stage paralysis. The results are considered with regard to possible mechanisms of chronic disease regulation in an environment of functional T cell suppression.This publication has 29 references indexed in Scilit:
- Unresponsiveness to experimental allergic encephalomyelitis in mice: replacement of suppressor cells by a soluble factor.The Journal of Immunology, 1981
- In vivo effects of antibodies to immune response gene products: prevention of experimental allergic encephalitis.Proceedings of the National Academy of Sciences, 1981
- The rapid isolation of clonable antigen‐specific T lymphocyte lines capable of mediating autoimmune encephalomyelitisEuropean Journal of Immunology, 1981
- A latent-relapsing neuroautoimmune disease in Syrian hamstersClinical Immunology and Immunopathology, 1980
- The presence of specific antigen-reactive cells during the induction, recovery, and resistance phases of experimental allergic encephalomyelitisCellular Immunology, 1980
- Antigen- and receptor-driven regulatory mechanisms. II. Induction of suppressor T cells with idiotype-coupled syngeneic spleen cells.The Journal of Experimental Medicine, 1979
- Antigen- and receptor-driven regulatory mechanisms. I. Induction of suppressor T cells with anti-idiotypic antibodies.The Journal of Experimental Medicine, 1979
- Experimental Allergic Encephalomyelitis in the Lewis Rat: Studies on the Mechanism of Recovery from Disease and Acquired Resistance to ReinductionThe Journal of Immunology, 1979
- Chronic experimental allergic encephalomyelitis in rhesus monkeys and its modification by treatmentJournal of the Neurological Sciences, 1978
- Immunoregulation of Experimental Allergic Encephalomyelitis: Conditions for Induction of Suppressor Cells and Analysis of MechanismThe Journal of Immunology, 1977